Susvimo (Page 7 of 7)

PRINCIPAL DISPLAY PANEL — Kit Carton

NDC 50242-078-55

Susvimo™
(ranibizumab injection)

See instructions for use
included with the
Susvimo ocular implantwith insertion tool assembly

100 mg/mL

Vial contains 10 mg/0.1 mL ranibizumab

For use with Susvimo ocular implant

Dispense the enclosed Medication Guide to each patient.

Carton contents:

  • One Susvimo single-dose vial
  • One Susvimo initial fill needle

Rx only

Genentech

10233586

PRINCIPAL DISPLAY PANEL -- Kit Carton
(click image for full-size original)

PRINCIPAL DISPLAY PANEL — 10 mg/0.1 mL Vial Carton

NDC 50242-078-12

Susvimo™
(ranibizumab injection)

100 mg/mL

Vial contains
10 mg/0.1 mL ranibizumab

For use with Susvimo
ocular implant

Dispense the enclosedMedication Guide to each patient.

Rx only

1 Single-dose vial

Genentech

10233583

PRINCIPAL DISPLAY PANEL -- 10 mg/0.1 mL Vial Carton
(click image for full-size original)
SUSVIMO ranibizumab injection, solution
Product Information
Product Type HUMAN PRESCRIPTION DRUG Item Code (Source) NDC:50242-078
Route of Administration INTRAVITREAL DEA Schedule
Active Ingredient/Active Moiety
Ingredient Name Basis of Strength Strength
RANIBIZUMAB (RANIBIZUMAB) RANIBIZUMAB 100 mg in 1 mL
Inactive Ingredients
Ingredient Name Strength
HISTIDINE
SUCROSE
POLYSORBATE 20
WATER
Packaging
# Item Code Package Description Multilevel Packaging
1 NDC:50242-078-12 1 VIAL in 1 CARTON contains a VIAL
1 1 mL in 1 VIAL This package is contained within the CARTON (50242-078-12)
2 NDC:50242-078-55 1 VIAL in 1 CARTON contains a VIAL
2 1 mL in 1 VIAL This package is contained within the CARTON (50242-078-55)
Marketing Information
Marketing Category Application Number or Monograph Citation Marketing Start Date Marketing End Date
BLA BLA761197 10/22/2021
Labeler — Genentech, Inc. (080129000)
Registrant — Genentech, Inc. (080129000)
Establishment
Name Address ID/FEI Operations
Roche Singapore Technical Operations Pte. Ltd. 937189173 ANALYSIS (50242-078), API MANUFACTURE (50242-078)
Establishment
Name Address ID/FEI Operations
Genentech, Inc. 080129000 ANALYSIS (50242-078)
Establishment
Name Address ID/FEI Operations
Genentech, Inc. 004074162 ANALYSIS (50242-078)
Establishment
Name Address ID/FEI Operations
Genentech, Inc. 833220176 PACK (50242-078), LABEL (50242-078), ANALYSIS (50242-078)

Revised: 11/2022 Genentech, Inc.

All MedLibrary.org resources are included in as near-original form as possible, meaning that the information from the original provider has been rendered here with only typographical or stylistic modifications and not with any substantive alterations of content, meaning or intent.

This site is provided for educational and informational purposes only, in accordance with our Terms of Use, and is not intended as a substitute for the advice of a medical doctor, nurse, nurse practitioner or other qualified health professional.

Privacy Policy | Copyright © 2023. All Rights Reserved.